169 related articles for article (PubMed ID: 36969883)
1. Investigating the Effect of Metabolic Phenotypes on Health Events in Alcoholic and Nonalcoholic Fatty Liver Disease.
Fan H; Zhang P; Liu Z; Zhao R; Suo C; Chen X; Zhang T
J Clin Transl Hepatol; 2023 Jun; 11(3):525-533. PubMed ID: 36969883
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease.
Liu Z; Suo C; Zhao R; Yuan H; Jin L; Zhang T; Chen X
Dig Liver Dis; 2021 Nov; 53(11):1435-1442. PubMed ID: 34348882
[TBL] [Abstract][Full Text] [Related]
3. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.
Chang Y; Ryu S; Sung KC; Cho YK; Sung E; Kim HN; Jung HS; Yun KE; Ahn J; Shin H; Wild SH; Byrne CD
Gut; 2019 Sep; 68(9):1667-1675. PubMed ID: 30472683
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey.
Kotronen A; Yki-Järvinen H; Männistö S; Saarikoski L; Korpi-Hyövälti E; Oksa H; Saltevo J; Saaristo T; Sundvall J; Tuomilehto J; Peltonen M
BMC Public Health; 2010 May; 10():237. PubMed ID: 20459722
[TBL] [Abstract][Full Text] [Related]
5. Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis.
Han AL
BMC Endocr Disord; 2021 May; 21(1):91. PubMed ID: 33933056
[TBL] [Abstract][Full Text] [Related]
6. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).
Johnston MP; Patel J; Byrne CD
Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662
[TBL] [Abstract][Full Text] [Related]
7. Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases.
Chang Y; Cho J; Cho YK; Cho A; Hong YS; Zhao D; Ahn J; Sohn CI; Shin H; Guallar E; Ryu S
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):205-215.e7. PubMed ID: 31085337
[TBL] [Abstract][Full Text] [Related]
8. Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population.
Kuang M; Lu S; Xie Q; Peng N; He S; Yu C; Qiu J; Sheng G; Zou Y
BMC Gastroenterol; 2022 Jun; 22(1):311. PubMed ID: 35752753
[TBL] [Abstract][Full Text] [Related]
9. Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease.
Sookoian S; Pirola CJ
PLoS One; 2013; 8(3):e58895. PubMed ID: 23516571
[TBL] [Abstract][Full Text] [Related]
10. Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease.
Lim J; Sang H; Kim HI
JHEP Rep; 2023 Jun; 5(6):100721. PubMed ID: 37138675
[TBL] [Abstract][Full Text] [Related]
11. A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population.
Zhang YC; Lyu ZY; Ma B; Li LM; Wang W; Sheng C; Dai HJ; Huang YB; Song FF; Song FJ; Chen KX
Hepatol Int; 2022 Aug; 16(4):835-845. PubMed ID: 35701716
[TBL] [Abstract][Full Text] [Related]
12. Association between non-alcoholic fatty liver disease and metabolically healthy deterioration across different body shape phenotypes at baseline and change patterns.
Lei L; Changfa W; Jiangang W; Zhiheng C; Ting Y; Xiaoling Z; Yuling D; Yaqin W
Sci Rep; 2022 Aug; 12(1):14786. PubMed ID: 36042236
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease.
Haflidadottir S; Jonasson JG; Norland H; Einarsdottir SO; Kleiner DE; Lund SH; Björnsson ES
BMC Gastroenterol; 2014 Sep; 14():166. PubMed ID: 25260964
[TBL] [Abstract][Full Text] [Related]
14. Association between metabolically healthy obesity and non-alcoholic fatty liver disease.
Man S; Lv J; Yu C; Deng Y; Yin J; Wang B; Li L; Liu H
Hepatol Int; 2022 Dec; 16(6):1412-1423. PubMed ID: 35987840
[TBL] [Abstract][Full Text] [Related]
15. Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.
Du T; Yu X; Yuan G; Zhang J; Sun X
Cardiovasc Diabetol; 2015 Oct; 14():144. PubMed ID: 26511621
[TBL] [Abstract][Full Text] [Related]
16. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
Chang Y; Jung HS; Cho J; Zhang Y; Yun KE; Lazo M; Pastor-Barriuso R; Ahn J; Kim CW; Rampal S; Cainzos-Achirica M; Zhao D; Chung EC; Shin H; Guallar E; Ryu S
Am J Gastroenterol; 2016 Aug; 111(8):1133-40. PubMed ID: 27185080
[TBL] [Abstract][Full Text] [Related]
17. Associations between metabolic dysfunction-associated fatty liver disease and extrahepatic cancers: a cohort in China.
Yuan X; Wang X; Wu S; Chen S; Wang Y; Wang J; Lu Y; Sun Y; Fu Q; Wang L
Hepatobiliary Surg Nutr; 2023 Oct; 12(5):671-681. PubMed ID: 37886198
[TBL] [Abstract][Full Text] [Related]
18. Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population: a cross-sectional study.
Kim HJ; Kim JH; Choe WH; Kwon SY; Lee CH
Clin Mol Hepatol; 2014 Jun; 20(2):154-61. PubMed ID: 25032181
[TBL] [Abstract][Full Text] [Related]
19. Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A United Kingdom population-based cohort study using the health improvement network (THIN).
Vusirikala A; Thomas T; Bhala N; Tahrani AA; Thomas GN; Nirantharakumar K
BMC Endocr Disord; 2020 Jun; 20(1):96. PubMed ID: 32605642
[TBL] [Abstract][Full Text] [Related]
20. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study.
Allen AM; Hicks SB; Mara KC; Larson JJ; Therneau TM
J Hepatol; 2019 Dec; 71(6):1229-1236. PubMed ID: 31470068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
